At Mitra, we are developing a skin longevity platform to enable development of therapeutics for the skin starting with skin aging. We believe skin aging and UV damage is a disease that can be reversed. We are using the power of next-generation sequencing, clinical-studies, and state-of-the-art data science to guide the design of anti-aging compounds effectively.
Mitra bio is an early-stage start-up backed by Illumina and the University of Oxford
There will be ample opportunity for growth in this role as the company expands with generous share options.